Search

Your search keyword '"Cordera S"' showing total 40 results

Search Constraints

Start Over You searched for: Author "Cordera S" Remove constraint Author: "Cordera S"
40 results on '"Cordera S"'

Search Results

1. Signs and symptoms of COVID-19 in patients with multiple sclerosis

2. The effect of air pollution on COVID-19 severity in a sample of patients with multiple sclerosis

3. Signs and symptoms of COVID-19 in patients with multiple sclerosis

4. SARS-CoV-2 serology after COVID-19 in multiple sclerosis: An international cohort study

5. Effect of SARS-CoV-2 mRNA vaccination in MS patients treated with disease modifying therapies

6. The Italian multiple sclerosis register

7. Disease modifying therapies and Covid‐19 severity in Multiple Sclerosis

8. Disease-Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis

10. Five-Year Survival after First-Ever Ischaemic Stroke Is Worse in Total Anterior Circulation Infarcts: The SINPAC Cohort

11. Association of genetic markers with CSF oligoclonal bands in multiple sclerosis patients

12. Stroke and transient ischaemic attack in 18 neurology departments from two Italian Regions: the SINPAC database

13. Endovascular Treatment for Acute Ischemic Stroke

14. Genetic burden of common variants in progressive and bout-onset multiple sclerosis

17. Risk of cancer in patients with Guillain-Barré syndrome (GBS). A population-based study

18. Validity of hospital morbidity records for amyotrophic lateral sclerosis. A population-based study

19. Association of Genetic Markers with CSF Oligoclonal Bands in Multiple Sclerosis Patients

20. Incidence of ALS in Italy: evidence for a uniform frequency in Western countries

22. Association of HLA class I markers with multiple sclerosis in the Italian and UK population: evidence of two independent protective effects

28. Guillain-Barré syndrome: A prospective, population-based incidence and outcome survey

29. Incidence of ALS in Italy: Evidence for a uniform frequency in Western countries

30. Effect of SARS-CoV-2 mRNA vaccination in multiple sclerosis patients treated with disease modifying therapies

32. Disease-Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis

34. Antibody response elicited by the SARS-CoV-2 vaccine booster in patients with multiple sclerosis: Who gains from it?

35. Breakthrough SARS-CoV-2 infections after COVID-19 mRNA vaccination in MS patients on disease modifying therapies during the Delta and the Omicron waves in Italy.

36. Effect of SARS-CoV-2 mRNA vaccination in MS patients treated with disease modifying therapies.

37. Association of supratotal resection with progression-free survival, malignant transformation, and overall survival in lower-grade gliomas.

38. MGMT promoter hypermethylation and its associations with genetic alterations in a series of 350 brain tumors.

39. Blood C-reactive protein concentration with ABCD² is a better prognostic tool than ABCD² alone.

40. Cerebral metastases as first symptom of cancer: a clinico-pathologic study.

Catalog

Books, media, physical & digital resources